John de Groot is Professor, and Chairman ad interim, in the Department of Neuro-Oncology at The University of Texas MD Anderson Cancer Center. He is an expert in the fields of glioma angiogenesis and molecularly targeted therapy. Professor de Groot completed his medical education at The University of Texas Medical Branch at Galveston, and pursued internship and residency at Johns Hopkins School of Medicine. Following a clinical fellowship at MD Anderson, he joined the faculty in 2004.
Professor de Groot has served as the principal investigator (PI) or co-investigator on multiple funded National Cancer Institute, foundation, and industry-sponsored grants. He is the PI of numerous clinical trials involving novel agents being tested in patients with glioblastoma and is a leader of MD Anderson’s Glioblastoma Moon Shot. As the previous fellowship program director and current interim Chair of Neuro-Oncology, he is also helping develop the next generation of neuro-oncologists. He has over one hundred peer reviewed articles, and is or has been a peer reviewer for 23 scientific journals, both national and international, and is a member of four editorial review boards.
Press return to search